Cargando…

CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: A systematic review and meta-analysis

BACKGROUND: CD133 is one of the most commonly used markers of cancer stem cells (CSCs), which are characterized by their ability for self-renewal and tumorigenicity. However, the clinical and prognostic significance of CD133 in gastric cancer remains controversial. To clarify a precise determinant o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiming, Li, Yunshan, Guo, Bo, Ma, Yu, Zang, Tao, Wei, Gengfang, Liang, Dexian, Fan, Shiqian, Cui, Jianli, Jiang, Juan, Tang, Zhinan, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747206/ https://www.ncbi.nlm.nih.gov/pubmed/26503471

Ejemplares similares

SNP rs2240688 in CD133 gene on susceptibility and clinicopathological features of hepatocellular carcinoma
por: Pan, Xiaolan, et al.
Publicado: (2020)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies
por: Huang, Rongyong, et al.
Publicado: (2018)

Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies: Erratum
Publicado: (2018)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma
por: Zhang, Jing, et al.
Publicado: (2016)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"
por: Ieni, Antonio, et al.
Publicado: (2016)

Overexpression of COX-2 and clinicopathological features of gastric cancer: a meta-analysis
por: Hu, Zhili, et al.
Publicado: (2020)

Correlation of CD133 and Oct-4 expression with clinicopathological and demographic parameters in oral squamous cell carcinoma patients
por: Singh, Alok, et al.
Publicado: (2018)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma
por: Xu, Bin, et al.
Publicado: (2021)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival
por: Zhang, Qingping, et al.
Publicado: (2019)

CD133 expression in different stages of gastric adenocarcinoma
por: Boegl, M, et al.
Publicado: (2009)

Clinicopathological and Prognostic Significance of CD24 Overexpression in Patients with Gastric Cancer: A Meta-Analysis
por: Wu, Jing-Xun, et al.
Publicado: (2014)

Impact of Age on Clinicopathological Features and Survival of Patients with Noncardia Gastric Adenocarcinoma
por: Bautista, Marita C, et al.
Publicado: (2014)

Clinicopathological Features and Postoperative Survival Analysis of Gastric Carcinoma with Neuroendocrine Differentiation
por: Liu, Jin, et al.
Publicado: (2022)

Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
por: Kim, Hyung-Don, et al.
Publicado: (2023)

Correlations Between Clinicopathological Features and the Vegetative Nervous System in Gastric Cancer
por: Balea, AM, et al.
Publicado: ( 201)

Clinicopathological Significance of NMIIA Overexpression in Human Gastric Cancer
por: Liu, Dongning, et al.
Publicado: (2012)

Reply: CD133 expression in different stages of gastric adenocarcinoma
por: Smith, L M, et al.
Publicado: (2009)

Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival
por: Weiss, Marjan M., et al.
Publicado: (2004)

Clinicopathological Correlation and Prognostic Significance of Protein Kinase Cα Overexpression in Human Gastric Carcinoma
por: Lin, Shee-Chan, et al.
Publicado: (2013)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival
por: Turkoz, Fatma Paksoy, et al.
Publicado: (2014)

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved
por: Lu, Li, et al.
Publicado: (2016)

The correlation of circulating pro‐angiogenic miRNAs’ expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer
por: Peng, Wei, et al.
Publicado: (2018)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Clinicopathologic and Prognostic Significance of Thymopoietin-α Overexpression in Gastric Cancer
por: Sun, Ding-Ping, et al.
Publicado: (2019)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer" and the "Commentary by Antonio Ieni and Giovanni Tuccari"
por: Fargeas, Christine A., et al.
Publicado: (2016)

Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
por: Zhao, Po, et al.
Publicado: (2010)

Overexpression of Ku80 correlates with aggressive clinicopathological features and adverse prognosis in esophageal squamous cell carcinoma
por: WANG, SHUAI, et al.
Publicado: (2015)

Clinicopathologic features of TDO2 overexpression in renal cell carcinoma
por: Pham, Quoc Thang, et al.
Publicado: (2021)

Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer
por: Tahara, Tomomitsu, et al.
Publicado: (2016)

Galectin-1 is overexpressed in CD133(+) human lung adenocarcinoma cells and promotes their growth and invasiveness
por: Zhou, Xuefeng, et al.
Publicado: (2014)

Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP
por: Sohn, Hong Moon, et al.
Publicado: (2019)

Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer
por: Chen, Di, et al.
Publicado: (2018)

Reduced FAF1 Expression and Helicobacter Infection: Correlations with Clinicopathological Features in Gastric Cancer
por: Liu, Ai-qun, et al.
Publicado: (2012)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis
por: Jia, Shengnan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_po62flph33jdejt9373aprfjio